Neural stem cells (NSCs) offer the potential to replace lost tissue after nervous system injury. Thus, stem cells can promote host neural repair in part by secreting growth factors, and their regeneration-promoting activities can be modified by gene delivery.
The central nervous system (CNS) is the part of the nervous system consisting of the brain and spinal cord. The central nervous system is so named because it integrates the received information and coordinates and influences the activity of all parts of the bodies and it contains the majority of the nervous system.
CNS conferences provide information regarding the current research and trends in CNS field.
The main topics discussed in the conference are Synapses and neurotransmission, White and gray matter, Cerebrovascular disorder, Neuroimmunological disorders, Neurodiagnosis and imaging procedures, Neurotherapeutics, Animal and Translational Models for CNS Drug Discovery , Electromyography, Neuropsychology and Behavioral Sciences, Neuropsychiatric disorders, Critical care neurology, Neurosurgery.
The global central nervous system drugs market was valued at around $71 billion in 2017. North America was the largest region in the CNS drugs market in 2017, holding nearly 40% market share. The USA was the largest country in the market in 2017, holding nearly 30% market share.
Neuroscientists, Neurologists, Directors, Physicians, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students
Hotel NH Valencia Center, Valencia, Spain